Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy - PubMed (original) (raw)

Comment

Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy

D S Geller et al. Science. 2000.

Abstract

Hypertension and pregnancy-related hypertension are major public health problems of largely unknown causes. We describe a mutation in the mineralocorticoid receptor (MR), S810L, that causes early-onset hypertension that is markedly exacerbated in pregnancy. This mutation results in constitutive MR activity and alters receptor specificity, with progesterone and other steroids lacking 21-hydroxyl groups, normally MR antagonists, becoming potent agonists. Structural and biochemical studies indicate that the mutation results in the gain of a van der Waals interaction between helix 5 and helix 3 that substitutes for interaction of the steroid 21-hydroxyl group with helix 3 in the wild-type receptor. This helix 5-helix 3 interaction is highly conserved among diverse nuclear hormone receptors, suggesting its general role in receptor activation.

PubMed Disclaimer

Comment on

• Hypertension. Mutation points to salt recycling pathway.
  Wickelgren I. Wickelgren I. Science. 2000 Jul 7;289(5476):23-6. doi: 10.1126/science.289.5476.23b. Science. 2000. PMID: 10928921 No abstract available.

Similar articles

• Hypertension. Mutation points to salt recycling pathway.
  Wickelgren I. Wickelgren I. Science. 2000 Jul 7;289(5476):23-6. doi: 10.1126/science.289.5476.23b. Science. 2000. PMID: 10928921 No abstract available.
• The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related.
  Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J, Vandewalle A. Rafestin-Oblin ME, et al. Endocrinology. 2003 Feb;144(2):528-33. doi: 10.1210/en.2002-220708. Endocrinology. 2003. PMID: 12538613
• Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.
  Pinon GM, Fagart J, Souque A, Auzou G, Vandewalle A, Rafestin-Oblin ME. Pinon GM, et al. Mol Cell Endocrinol. 2004 Mar 31;217(1-2):181-8. doi: 10.1016/j.mce.2003.10.053. Mol Cell Endocrinol. 2004. PMID: 15134816
• Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
  Baker ME, Funder JW, Kattoula SR. Baker ME, et al. J Steroid Biochem Mol Biol. 2013 Sep;137:57-70. doi: 10.1016/j.jsbmb.2013.07.009. Epub 2013 Jul 29. J Steroid Biochem Mol Biol. 2013. PMID: 23907018 Review.
• [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
  Arai K, Shibasaki T. Arai K, et al. Nihon Rinsho. 2002 Feb;60(2):361-6. Nihon Rinsho. 2002. PMID: 11857927 Review. Japanese.

Cited by

• Endocrine causes of heart failure: A clinical primer for cardiologists.
  Khatiwada S, Boro H, Farooqui FA, Alam S. Khatiwada S, et al. Indian Heart J. 2021 Jan-Feb;73(1):14-21. doi: 10.1016/j.ihj.2020.11.003. Epub 2020 Nov 11. Indian Heart J. 2021. PMID: 33714404 Free PMC article. Review.
• Genes for blood pressure: an opportunity to understand hypertension.
  Ehret GB, Caulfield MJ. Ehret GB, et al. Eur Heart J. 2013 Apr;34(13):951-61. doi: 10.1093/eurheartj/ehs455. Epub 2013 Jan 9. Eur Heart J. 2013. PMID: 23303660 Free PMC article. Review.
• Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
  Amazit L, Le Billan F, Kolkhof P, Lamribet K, Viengchareun S, Fay MR, Khan JA, Hillisch A, Lombès M, Rafestin-Oblin ME, Fagart J. Amazit L, et al. J Biol Chem. 2015 Sep 4;290(36):21876-89. doi: 10.1074/jbc.M115.657957. Epub 2015 Jul 22. J Biol Chem. 2015. PMID: 26203193 Free PMC article.
• A Natural Mutation in Helix 5 of the Ligand Binding Domain of Glucocorticoid Receptor Enhances Receptor-Ligand Interaction.
  Reyer H, Ponsuksili S, Kanitz E, Pöhland R, Wimmers K, Murani E. Reyer H, et al. PLoS One. 2016 Oct 13;11(10):e0164628. doi: 10.1371/journal.pone.0164628. eCollection 2016. PLoS One. 2016. PMID: 27736993 Free PMC article.
• The molecular basis of blood pressure variation.
  Toka HR, Koshy JM, Hariri A. Toka HR, et al. Pediatr Nephrol. 2013 Mar;28(3):387-99. doi: 10.1007/s00467-012-2206-9. Epub 2012 Jul 5. Pediatr Nephrol. 2013. PMID: 22763847 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • The Weizmann Institute of Science GeneCards and MalaCards databases